Literature DB >> 10671885

The histological extent of the local spread of carcinoma of the penis and its therapeutic implications.

A Agrawal1, D Pai, N Ananthakrishnan, S R Smile, C Ratnakar.   

Abstract

OBJECTIVE: To explore the possibility of reducing the margin of clearance at surgery for carcinoma of the penis without causing an increase in the incidence of local tumour recurrence, so that the functional and cosmetic compromise associated with penectomy might be minimized. PATIENTS AND METHODS: Sixty-four patients underwent partial or total penectomy based on the extent of tumour. The specimens were evaluated histologically for grade and for proximal microscopic extensions beyond the grossly visible tumour margin, by examining serial proximal 5 mm sections. The histological grade of the lesion was correlated with its clinical site, morphology and proximal microscopic spread. Differences were assessed using the chi-squared test.
RESULTS: Of 64 tumours, 31% were grade 1, 50% grade 2 and the remaining 19% grade 3. Higher grade lesions were more likely to involve the penile shaft. The maximum proximal histological extent was 5 mm for grades 1 and 2, and 10 mm for grade 3 tumours; there was no discontinuous spread.
CONCLUSIONS: Histological grading is mandatory in the management of carcinoma of the penis. A 10-mm clearance is adequate for grade 1 and 2 lesions, and 15 mm for grade 3 tumours. This approach would qualify more patients for partial rather than total amputation; the residual length of the penis would then be cosmetically and functionally more acceptable.

Entities:  

Mesh:

Year:  2000        PMID: 10671885     DOI: 10.1046/j.1464-410x.2000.00413.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

1.  Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results?

Authors:  Omid Sedigh; Marco Falcone; Carlo Ceruti; Massimiliano Timpano; Mirko Preto; Marco Oderda; Franklin Kuehhas; Mattia Sibona; Arianna Gillo; Paolo Gontero; Luigi Rolle; Bruno Frea
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 2.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 3.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

4.  Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis.

Authors:  Yao Zhu; Wei-Jie Gu; Hong-Kai Wang; Cheng-Yuan Gu; Ding-Wei Ye
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

Review 5.  Penile preserving and reconstructive surgery in the management of penile cancer.

Authors:  Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

Review 6.  Challenges and controversies in the management of penile cancer.

Authors:  Majid Shabbir; Oliver Kayes; Suks Minhas
Journal:  Nat Rev Urol       Date:  2014-11-18       Impact factor: 14.432

Review 7.  Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience.

Authors:  Paul K Hegarty; Majid Shabbir; Ben Hughes; Suks Minhas; Matthew Perry; Nicholas Watkin; David J Ralph
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

Review 8.  [Local treatment of penile cancer].

Authors:  C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

9.  Current and future strategies in the diagnosis and management of penile cancer.

Authors:  Samuel M Lawindy; Alejandro R Rodriguez; Simon Horenblas; Philippe E Spiess
Journal:  Adv Urol       Date:  2011-05-30

10.  Penis auto-amputation and chasm of the lower abdominal wall due to advanced penile carcinoma: a case report.

Authors:  Dimitrios Baltogiannis; Konstantinos Zotos; Stavros Tsambalas; Dimitrios Giannakis; Nikolaos Sofikitis
Journal:  J Med Case Rep       Date:  2011-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.